Multiresistant non-fermentative Gram-negative bacteria in cystic fibrosis patients: The results of an Italian multicenter study

European Journal of Epidemiology

Volumn 15, Issue 1, 1999, Pages 85-88

  Taccetti, Giovanni ^a   Campana, Silvia ^b   Marianelli, Lore ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b NONE

Author keywords

Burkholderia cepacia; Cystic fibrosis; Microbiology; Pseudomonas aeruginosa

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; AZTREONAM; BETA LACTAM ANTIBIOTIC; CEFTAZIDIME; IMIPENEM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE; TICARCILLIN; TOBRAMYCIN; UREIDOPENICILLIN;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATION; CHILD; CYSTIC FIBROSIS; DRUG CHOICE; DRUG EFFICACY; FEMALE; GRAM NEGATIVE BACTERIUM; HUMAN; INFANT; ITALY; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; NEWBORN; PREVALENCE;

ADOLESCENT; ADULT; BURKHOLDERIA CEPACIA; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; DRUG RESISTANCE, MICROBIAL; FEMALE; GRAM-NEGATIVE AEROBIC BACTERIA; HUMANS; INFANT; ITALY; MALE; PSEUDOMONAS AERUGINOSA;

EID: 0032914844     PISSN: 03932990     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007504524034     Document Type: Article

References (21)

1. Davis PB, Drumm M, Konstan MW. Cystic fibrosis. Am J Respir Crit Care Med 1996; 154: 1229-1256.
2. Hilman BC, Lewiston NJ. Clinical manifestations of cystic fibrosis. In: Hilman BC (ed), Pediatric respiratory disease: Diagnosis and treatment. Philadelphia: Saunders, 1993: 661-673.
3. Hoiby N. Microbiology of cystic fibrosis. In: Hodson ME, Geddes DM (eds), Cystic fibrosis. London: Chapman & Hall, 1995: 75-98.
4. Gilligan PH. Microbiology of airway disease in patients with cystic fibrosis. Clin Microbiol Rev 1991; 4: 35-51.
5. Govan JRW, Nelson JW. Microbiology of lung infection in cystic fibrosis. Br Med Bull 1992; 48: 919-930.
6. Govan JRW, Deretic V. Microbial pathogenesis in cystic fibrosis: Mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 1996; 60: 539-574.
7. Vandamme P, Holmes B, Vancanneyt M, Coenye T, Hoste B, Coopman R, Revets H, Lauwers S, Gillis M, Kerster K, Govan JRW. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp.nov. Int J Syst Bacteriol 1997; 47: 1188-1200.
8. Cazzola G, Amalfitano G, Tonolli E, Perazzoli E, Piacentini I, Mastella G. Burkholderia (Pseudomonas) cepacia epidemiology in a cystic fibrosis population: A genome finger-printing study. Acta Paediatr 1996; 85: 554-557.
9. Cheng K, Smyth RL, Govan JRW, Doherty C, Winstanley C, Denning N, Heaf DP, van Saenen H, Hart CA. Spread of β-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. Lancet 1996; 348: 639-642.
10. Isles A, Macluskey I, Corey M, Gold R, Prober C, Fleming P, Levison H. Pseudomonas cepacia infection in cystic fibrosis: An emerging problem. J Pediatr 1984; 104: 206-210.
11. Saiman L, MacDonald NE, Whittier S. The microbiological basis for antimicrobial therapy. Tenth Annual North American Cystic Fibrosis Conference. Cystic Fibrosis Foundation, Orlando, October 24 1996.
12. Bossi A, Padoan R, Gagliardini R, Manca A, Zanda M, Miano A, Marianelli L, Romano L, Magazzù G, Raia V, Pardo F, Grzincich G, Salvatore D, Quattrucci S, de Candussio G, Lucidi V, Faraguna D, Mastella G, Giunta A. The Italian Cystic Fibrosis patients registry. 20th European Cystic Fibrosis Conference. Brussels, 18-21 June 1995. P39.
13. Taccetti G, Campana S. Microbiologic data overview of Italian cystic fibrosis patients. Eur J Epidemiol 1997; 13: 323-327.
14. Cystic Fibrosis Foundation. Microbiology and infectious disease in cystic fibrosis. Bethesda, Maryland, August 1996.
15. Cystic Fibrosis Foundation, Consensus Conference -Microbiology and infectious disease in Cystic Fibrosis, Bethesda, Maryland, 17-18 May 1994 (Vol V; Section I: 19).
16. Cystic Fibrosis Foundation. Patient Registry 1993 Annual Data Report. Bethesda, Maryland, September 1994.
17. FitzSimmons SC. The changing epidemiology of cystic fibrosis. J Pediatr 1993; 122: 1-9.
18. Observatoire National de la Mucoviscidose. Epidemiology of cystic fibrosis in France. Pediatr Pulmonol 1995; 19 (suppl 12); A380.
19. Bingen E, Botzenhart K, Chabanon G, Doring G, Govan J, Hoiby N, LiPuma JJ, Michel-Briand Y, Ogle J, Romling U, Smith A, Speert D, Stern R, Tablan O, Wolz C. Epidemiology of pulmonary infections by Pseudomonas in patients with cystic fibrosis: A consensus report. In: Doing G, Schaffar L (eds), Paris: French Cystic Fibrosis Association, 1993: 9-11.
20. Winnie G, Hartigan E, Holt L. Chronic Alcaligenes xylosoxidans respiratory tract infection in patients with cystic fibrosis. Pediatr Pulmonol 1996; 20 (suppl 13) A321.
21. Goldfarb J. New antimicrobial agents. Pediatr Clin North Am 1995; 42: 717-735.